HINYE
LIVE

Serial Number

79304188

Owner

Hinye Pharmaceutical Co.,Ltd.

Attorney

Di Li

Filing Date

Sep 25, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HINYE Trademark

Serial Number: 79304188 • Registration: 6488785

HINYE is a trademark filed by Hinye Pharmaceutical Co.,Ltd. on September 25, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Hinye Pharmaceutical Co.,Ltd. (3 trademarks)

No.109 Kangtian Road,

Entity Type: 03

Trademark Details

Filing Date

September 25, 2020

Registration Date

September 21, 2021

Published for Opposition

July 6, 2021

Goods & Services

Herbal supplements; medicinal herbal preparations; medicinal herbs; herbs for medicinal purposes; chinese traditional medicinal herbs; medicinal herbal extracts for medical purposes; medicines for the treatment of gastrointestinal diseases; antiallergic medicines; medicines for alleviating constipation; pharmaceutical preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; pharmaceutical preparations for the prevention of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; chemical preparations for pharmaceutical or medical purposes, namely, for cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; unit dose capsules sold empty for pharmaceutical use; biological preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; allergy tablets; antibiotic tablets

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 4, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 10, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 10, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 21, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 21, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 6, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 16, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 26, 2021 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 5, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 5, 2021 RFRR
APPLICATION FILING RECEIPT MAILED
Feb 27, 2021 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 25, 2021 RFCR
NON-FINAL ACTION WRITTEN
Feb 24, 2021 CNRT
ASSIGNED TO EXAMINER
Feb 23, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 18, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 11, 2021 REPR